A MULTIPLE SCLEROSIS drug pulled from the US market last year is to return and has also been given preliminary approval for use in Europe, a move that will be welcomed by the 6,000 Irish people affected by the condition.

The US government has asked pharmaceutical giant Pfizer to withdraw the painkiller Bextra from the market because it increases the risk of heart attack and stroke.